VOLPINI, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.336
EU - Europa 8.985
AS - Asia 7.033
SA - Sud America 960
AF - Africa 258
Continente sconosciuto - Info sul continente non disponibili 50
OC - Oceania 13
Totale 36.635
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.723
CN - Cina 2.855
SG - Singapore 2.156
RU - Federazione Russa 1.958
PL - Polonia 1.552
IT - Italia 1.448
DE - Germania 974
BR - Brasile 801
GB - Regno Unito 624
HK - Hong Kong 557
UA - Ucraina 539
CA - Canada 524
SE - Svezia 524
FR - Francia 523
VN - Vietnam 483
FI - Finlandia 365
KR - Corea 230
TR - Turchia 219
ZA - Sudafrica 181
IE - Irlanda 137
IN - India 120
JP - Giappone 102
MX - Messico 65
NL - Olanda 63
AR - Argentina 55
BE - Belgio 49
EU - Europa 49
ES - Italia 46
BD - Bangladesh 44
CZ - Repubblica Ceca 37
IQ - Iraq 35
IR - Iran 33
AT - Austria 28
EC - Ecuador 26
VE - Venezuela 21
PK - Pakistan 20
RO - Romania 18
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 17
CO - Colombia 17
ID - Indonesia 17
TW - Taiwan 17
LT - Lituania 16
SA - Arabia Saudita 15
CH - Svizzera 14
KE - Kenya 14
IL - Israele 13
CL - Cile 12
JO - Giordania 12
PY - Paraguay 12
TN - Tunisia 12
MA - Marocco 11
RS - Serbia 11
AZ - Azerbaigian 9
DZ - Algeria 9
PE - Perù 9
PH - Filippine 9
AU - Australia 8
EG - Egitto 8
NP - Nepal 8
DK - Danimarca 7
LB - Libano 7
BG - Bulgaria 6
AM - Armenia 5
CI - Costa d'Avorio 5
GR - Grecia 5
LV - Lettonia 5
MY - Malesia 5
PA - Panama 5
TH - Thailandia 5
AL - Albania 4
BO - Bolivia 4
GE - Georgia 4
HR - Croazia 4
JM - Giamaica 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
BY - Bielorussia 3
CR - Costa Rica 3
EE - Estonia 3
ET - Etiopia 3
GT - Guatemala 3
KH - Cambogia 3
LU - Lussemburgo 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
CM - Camerun 2
DO - Repubblica Dominicana 2
GA - Gabon 2
HU - Ungheria 2
KW - Kuwait 2
MT - Malta 2
MU - Mauritius 2
OM - Oman 2
SC - Seychelles 2
SI - Slovenia 2
SN - Senegal 2
Totale 36.614
Salva come PNG Salva come JPEG
Città #
Fairfield 1.762
Ashburn 1.576
Woodbridge 1.493
Warsaw 1.349
Jacksonville 1.323
Singapore 1.075
Houston 1.068
Chandler 1.053
San Jose 913
Seattle 783
Wilmington 754
Ann Arbor 647
Cambridge 605
Boardman 565
Dallas 564
Hong Kong 529
Nanjing 463
Beijing 445
Toronto 332
The Dalles 279
Los Angeles 258
Council Bluffs 254
Camerino 247
Seoul 205
New York 203
San Mateo 199
Columbus 190
Tongling 189
Dearborn 188
Kraków 185
Princeton 181
Lawrence 180
Düsseldorf 175
Helsinki 173
Istanbul 168
Lauterbourg 162
Johannesburg 160
Ogden 146
Ho Chi Minh City 145
Dublin 136
Buffalo 132
London 130
Lachine 128
Moscow 124
Nanchang 123
Hanoi 110
Santa Clara 106
Shanghai 104
Chicago 100
Guangzhou 97
Shenyang 91
São Paulo 91
Milan 90
Munich 88
Tianjin 87
San Diego 84
Tokyo 81
Frankfurt am Main 78
Kunming 74
Hebei 62
Jiaxing 56
Orem 54
Brussels 48
Edinburgh 46
Changsha 42
Rome 42
St Louis 41
Phoenix 40
Wuhan 40
Jinan 39
Redwood City 39
Denver 38
Ningbo 38
Centro 37
Hangzhou 36
Atlanta 35
Dong Ket 35
Stockholm 35
Manchester 34
Trieste 33
Boston 31
Philadelphia 31
Turku 31
Venezia 31
Brooklyn 30
Zhengzhou 30
Poplar 29
San Francisco 29
Verona 29
Chennai 28
Hefei 27
Rio de Janeiro 27
Montreal 26
Brno 25
Falls Church 25
Mexico City 25
Norwalk 25
Amsterdam 24
Orange 24
Ascoli Piceno 23
Totale 24.660
Salva come PNG Salva come JPEG
Nome #
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 644
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 450
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 403
Overview on Radiolabel-Free in Vitro Assays for GPCRs 399
Pharmacological characterization of the GPR17 receptor dual profile 393
GPR17 receptor modulators and their therapeutic implications: review of recent patents 389
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 384
The G Protein-Coupled Receptor GPR17: Overview and Update 370
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 363
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 355
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 325
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 297
Medicinal chemistry and pharmacology of A2B adenosine receptors 297
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 293
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones 289
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 282
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 274
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 274
2-Aralkynyl and 2-Heteroalkynyl derivatives of Adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists 268
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 265
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 264
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 264
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 262
2-Substituted N-ethylcarboxamidoadenosine derivatives as high affinity agonists at human A(3) adenosine receptors 259
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors 251
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 250
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 248
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 247
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 247
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 244
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 243
2-Alkynyl derivatives of Adenosine-5'-N-ethyluronamide (NECA): selective A2 adenosine receptor agonists with potent inhibitory activity on Platelet aggregation 242
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 240
Human cytidine deaminase: understanding the catalytic mechanism 239
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model 239
Human placenta cytidine deaminase: a zinc metalloprotein 238
Isoenzymatic forms of human cytidine deaminase 237
Determination of ink photoinitiators in packaged beverages by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry 237
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 236
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 234
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 234
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 233
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 233
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 232
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 231
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 230
New sensible method to quantize the intestinal absorption of receptor ligands 224
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 223
Adenosine deaminase: Functional implications and different classes of inhibitors 223
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles 223
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 220
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 219
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 218
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 217
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 217
Antiviral activity of purine nucleoside analogs against bovine herpesvirus (BHV-1) and maedi visna virus (MVV) 216
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors 215
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. 214
Antiviral properties of deazaadenine nucleoside derivatives 214
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 213
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 212
"N-Cycloalkylalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists at the A1 adenosine receptor 210
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 210
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 210
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 208
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 206
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 204
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 204
Adenosine receptor modeling: what does the A2A crystal structure tell us? 204
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 204
Diazepinone nucleosides as inhibitors of cytidine deaminase 203
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 203
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 203
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 202
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases 202
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 198
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 198
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 198
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 196
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 196
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 195
2-ChloroATP exerts anti-tumoral actions not mediated by P2 receptors in neuronal and glial cells line 193
Chemical and pharmacological profile of selective adenosine receptor agonists 193
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 193
Unexpected synthesis of acyclic adenine nucleosides 191
Synthesis and receptor affinity of polysubstituted adenosines 191
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 189
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 189
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 188
Adenosine deaminase inhibitors: structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogs 187
Potent and selective ligands for adenosine binding sites 186
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 186
Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity 185
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 185
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A1/A2B Partial Agonists 184
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 183
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution result in distinct selectivities. 183
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 183
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 183
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide 181
Totale 24.203
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 0 0 388
2021/20222.229 234 534 55 91 122 119 102 167 170 235 157 243
2022/20232.525 256 144 76 420 277 361 11 154 461 134 165 66
2023/20241.883 265 100 110 76 87 173 87 104 222 62 49 548
2024/20256.213 231 140 527 295 200 361 709 1.540 518 436 382 874
2025/20268.825 538 524 1.072 1.240 984 701 1.487 581 511 580 482 125
Totale 37.113